1-5 of 5
Masoud H Manjili, DVM, PhD
Close
Sort by
Journal Articles

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Radhika Thorn, MD, Jeremy Meier, BS, Elaine Wang, MD, Roy T Sabo, PhD, Allison F Scalora, MS, Catherine H Roberts, PhD, Shiyu Song, MD, PhD, Masoud H Manjili, DVM, PhD, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Amir A Toor, MD
Journal: Blood
Blood (2013) 122 (21): 4577.
https://doi.org/10.1182/blood.V122.21.4577.4577
Published: 2013
Journal Articles

Whole Exome Sequencing To Estimate Alloreactivity Potential Between Donors and Recipients In Stem Cell Transplantation

Juliana Sampson, PhD, Nihar Sheth, PhD, Vishal N Koparde, PhD, Allison Scalora, MS, Myrna G Serrano, PhD, Vladimir Lee, PhD, Maximillian Jamison-Lee, PhD, Andrea Ferreira-Gonzalez, PhD, Catherine H Roberts, PhD, Masoud H Manjili, DVM, PhD, Gregory Buck, PhD, Michael C Neale, PhD, Amir A Toor MD
Journal: Blood
Blood (2013) 122 (21): 150.
https://doi.org/10.1182/blood.V122.21.150.150
Published: 2013
Journal Articles

Fractal Organization of the Human T Cell Repertoire in Health and Following Stem Cell Transplantation

Jeremy Meier, Allison F Hazlett, MS, Kassi Avent, MS, Jennifer Berrie, Kyle Payne, David Hamm, MS, Cindy Desmarais, PhD, Catherine Sanders, PhD, Kevin T Hogan, PhD, Steven Grant, MD, Kellie J Archer, PhD, Masoud H Manjili, DVM, PhD, Catherine Roberts, PhD, Amir A Toor, MD
Journal: Blood
Blood (2012) 120 (21): 4193.
https://doi.org/10.1182/blood.V120.21.4193.4193
Published: 2012
Journal Articles

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Amir A Toor, MD, Roy T Sabo, PhD, Harold M Chung, MD, Catherine H Roberts, PhD, Rose H Manjili, BS, Shiyu Song, MD, PhD, David C. Williams, Jr., MD, PhD, William Clark, MD, Masoud H Manjili, DVM, PhD, John M McCarty, MD
Journal: Blood
Blood (2011) 118 (21): 3043.
https://doi.org/10.1182/blood.V118.21.3043.3043
Published: 2011
Journal Articles

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Amir A Toor, MD, Kyle Payne, BS, Harold M Chung, MD, Catherine H Roberts, PhD, Roy T Sabo, PhD, Maciej Kmieciak, PhD, William Clark, MD, Christy McLaughlin, BS, Angela Buskey, RN, Jennifer Anderson, RN, Rose H Manjili, BS, Susan D. Roseff, MD, John M McCarty, MD, Masoud H Manjili, DVM, PhD
Journal: Blood
Blood (2011) 118 (21): 2926.
https://doi.org/10.1182/blood.V118.21.2926.2926
Published: 2011